Cosman Medical, Inc. Sustainability Profile
Cosman Medical, Inc., headquartered in the United States, is a leading innovator in the medical device industry, specialising in advanced pain management solutions. Founded in 1976, the company has established a strong presence in major operational regions across North America and Europe, focusing on the development of cutting-edge radiofrequency (RF) technology. Cosman Medical is renowned for its unique RF generators and electrodes, which are designed to provide precise and effective pain relief for patients suffering from chronic conditions. The company’s commitment to quality and innovation has positioned it as a trusted partner in the healthcare sector, with notable achievements in enhancing patient outcomes through minimally invasive procedures. With decades of expertise, Cosman Medical continues to set the standard in pain management technology.
DitchCarbon Score
How does Cosman Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cosman Medical, Inc.'s score of 97 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cosman Medical, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. However, the company is part of a corporate family that includes Boston Scientific Corporation, from which it inherits climate commitments and initiatives. Boston Scientific Corporation has established significant climate commitments, including science-based targets for emissions reductions. These targets are cascaded to Cosman Medical, Inc. at a level 2 relationship, indicating that the parent company’s sustainability goals influence the subsidiary's climate strategies. While specific reduction targets for Cosman Medical, Inc. are not detailed, the overarching initiatives from Boston Scientific include participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which aim to drive substantial reductions in greenhouse gas emissions across their operations. As part of its commitment to sustainability, Cosman Medical, Inc. aligns with industry standards and practices, although specific metrics and achievements related to emissions reductions are not available at this time. The company is expected to adhere to the climate pledges and initiatives set forth by its parent organisation, Boston Scientific Corporation, as it continues to develop its own environmental strategies.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - | 0,000,000,000 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Cosman Medical, Inc.'s Industry?
How Carbon Intensive is Cosman Medical, Inc.'s Location?
Cosman Medical, Inc.'s Scope 3 Categories Breakdown
Cosman Medical, Inc.'s Scope 3 emissions, which increased by 28% last year and decreased by approximately 7% since 2019, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 57% of Scope 3 emissions.
Top Scope 3 Categories
Cosman Medical, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cosman Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
